Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SANOFI PASTEUR INC.

Home Clinical Trial Sponsors and OrganizationsSANOFI PASTEUR INC.

SANOFI PASTEUR INC.

50 Stauffer Industrial Park, Taylor, Pennsylvania, United States

Also known as:

aventis pasteur

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

32

26 active

Approvals

15

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

14

43.8%

Phase 3

6

18.8%

Phase 2

2

6.3%

Unknown

2

6.3%

Trial Status Distribution

Active, not recruiting

21

65.6%

Not yet recruiting

5

15.6%

Recruiting

6

18.8%

Clinical Trials

Trials sponsored by this organization (32)

Study to evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults with Moderate to Severe Acne

Aug 2026189 participants

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Not yet recruiting

Sep 20246,000 participants

A study of Chlamydia trachomatis infection and reinfection in young adults

Mar 2024200 participants

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Active, not recruiting

Jan 20246,300 participants

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Active, not recruiting

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

Not yet recruiting

Aug 20231,000 participants

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Not yet recruiting

Jul 20231,350 participants

Study of a novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Active, not recruiting

Page 1 of 4

Approvals

Approvals by Agency

FDA

Food and Drug Administration

15

Approvals

Recent Approvals

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

News

No news articles found

On this page

Overview
Clinical Trials32
Approvals15
News

Back to Organizations